Brain activity response to cues during gait in Parkinson's disease: A study protocol

Rodrigo Vitório, Rosie Morris, Julia Das, Richard Walker, Martina Mancini, Samuel Stuart, Rodrigo Vitório, Rosie Morris, Julia Das, Richard Walker, Martina Mancini, Samuel Stuart

Abstract

Various cueing strategies (internal and external) have been used to alleviate gait deficits in Parkinson's disease (PD). However, it remains unclear which type of cueing strategy is most effective at different disease stages or with more severe walking impairment, such as freezing of gait (FOG). The underlying neural mechanisms of response to cueing are also unknown. This trial aims to: (i) determine brain activity response to cue stimulus (internal, visual, auditory or tactile) when walking in PD and; (ii) examine changes in brain activity to cues at different stages of PD. This ongoing single-site study uses an exploratory observational design, with laboratory application of cues for gait deficit. A total of 80 people with PD who meet the inclusion criteria will be enrolled. Participants are split into groups dependent on their disease stage (classified with the Hoehn and Yahr (H&Y) scale); n = 20 H&YI; n = 30 H&YII; n = 30 H&YIII. Within the H&Y stage II and III groups, we will also ensure recruitment of a sub-group of 15 individuals with FOG within each group. Participants perform walking tasks under several conditions: baseline walking without cues; randomized cued walking conditions [internal and external (visual, auditory and tactile) cues]. A combined functional near-infrared spectroscopy and electroencephalography system quantifies cortical brain activity while walking. Inertial sensors are used to assess gait. Primary outcome measures are cue-related changes in cortical brain activity while walking, including the relative change in cortical HbO2 and the power spectral densities at alpha (8-13Hz), beta (13-30Hz), delta (0.5-4Hz), theta (4-8Hz) and gamma (30-40Hz) frequency bandwidths. Secondary outcome measures are cue-related changes in spatiotemporal gait characteristics. Findings will enhance our understanding about the cortical responses to different cueing strategies and how they are influenced by PD progression and FOG status. This trial is registered at clinicaltrials.gov (NCT04863560; April 28, 2021, https://ichgcp.net/clinical-trials-registry/NCT04863560).

Conflict of interest statement

The authors have declared that no competing interests exist.

Copyright: © 2022 Vitório et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Figures

Fig 1. SPIRIT template for the schedule…
Fig 1. SPIRIT template for the schedule of enrolment, interventions, and assessments.
Fig 2. Flowchart of the study.
Fig 2. Flowchart of the study.

References

    1. Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, et al.. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019;18(7):697–708. doi: 10.1016/S1474-4422(19)30044-4
    1. Muslimović D, Post B, Speelman JD, Schmand B, de Haan RJ, For the CSG. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008;70(23):2241–7. doi: 10.1212/01.wnl.0000313835.33830.80
    1. Giladi N, Treves TA, Simon ES, Shabtai H, Orlov Y, Kandinov B, et al.. Freezing of gait in patients with advanced Parkinson’s disease. Journal of Neural Transmission. 2001;108(1):53–61. doi: 10.1007/s007020170096
    1. Prasad S, Lenka A, Stezin A, Naduthota RM, Jha M, Yadav R, et al.. A Comparative Study of Early and Late Onset Freezing of Gait in Parkinson’s Disease. Ann Indian Acad Neurol. 2018;21(4):256–62. doi: 10.4103/aian.AIAN_459_17
    1. Heremans E, Nieuwboer A, Vercruysse S. Freezing of gait in Parkinson’s disease: where are we now? Current neurology and neuroscience reports. 2013;13(6):350. doi: 10.1007/s11910-013-0350-7
    1. Maidan I, Nieuwhof F, Bernad-Elazari H, Reelick MF, Bloem BR, Giladi N, et al.. The Role of the Frontal Lobe in Complex Walking Among Patients With Parkinson’s Disease and Healthy Older Adults: An fNIRS Study. Neurorehabilitation and neural repair. 2016;30(10):963–71. doi: 10.1177/1545968316650426
    1. Orcioli-Silva D, Vitório R, Beretta VS, da Conceição NR, Nóbrega-Sousa P, Oliveira AS, et al.. Is Cortical Activation During Walking Different Between Parkinson’s Disease Motor Subtypes? The journals of gerontology Series A, Biological sciences and medical sciences. 2021;76(4):561–7. doi: 10.1093/gerona/glaa174
    1. Vitorio R, Stuart S, Mancini M. Executive Control of Walking in People With Parkinson’s Disease With Freezing of Gait. Neurorehabilitation and neural repair. 2020;34(12):1138–49. doi: 10.1177/1545968320969940
    1. Gilat M, Bell PT, Ehgoetz Martens KA, Georgiades MJ, Hall JM, Walton CC, et al.. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease. Neuroimage. 2017;152:207–20. doi: 10.1016/j.neuroimage.2017.02.073
    1. Wilson J, Alcock L, Yarnall AJ, Lord S, Lawson RA, Morris R, et al.. Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology. Frontiers in aging neuroscience. 2020;12:577435. doi: 10.3389/fnagi.2020.577435
    1. Sethi K. Levodopa unresponsive symptoms in Parkinson disease. Movement disorders. 2008;23 Suppl 3:S521–33. doi: 10.1002/mds.22049
    1. Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson’s Disease. Movement disorders: official journal of the Movement Disorder Society. 2015;30(10):1361–70. doi: 10.1002/mds.26269
    1. Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JCT, et al.. Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology. 2016;15(3):249–58. doi: 10.1016/S1474-4422(15)00389-0
    1. Stuart S, Morris R, Giritharan A, Quinn J, Nutt JG, Mancini M. Prefrontal Cortex Activity and Gait in Parkinson’s Disease With Cholinergic and Dopaminergic Therapy. Movement disorders: official journal of the Movement Disorder Society. 2020;35(11):2019–27. doi: 10.1002/mds.28214
    1. Vitorio R, Stuart S, Giritharan A, Quinn J, Nutt JG, Mancini M. Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson’s disease: A randomized cross-over trial. Parkinsonism & related disorders. 2021;86:10–4. doi: 10.1016/j.parkreldis.2021.03.014
    1. Wilkins KB, Parker JE, Bronte-Stewart HM. Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson’s disease. Neurobiol Dis. 2020;146:105134. doi: 10.1016/j.nbd.2020.105134
    1. Buhmann C, Huckhagel T, Engel K, Gulberti A, Hidding U, Poetter-Nerger M, et al.. Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences. PLoS One. 2017;12(7):e0178984. doi: 10.1371/journal.pone.0178984
    1. Munoz-Hellin E, Cano-de-la-Cuerda R, Miangolarra-Page JC. Visual cues as a therapeutic tool in Parkinson’s disease. A systematic review. Revista espanola de geriatria y gerontologia. 2013;48(4):190–7.
    1. Vitório R, Lirani-Silva E, Pieruccini-Faria F, Moraes R, Gobbi LT, Almeida QJ. Visual cues and gait improvement in Parkinson’s disease: which piece of information is really important? Neuroscience. 2014;277:273–80. doi: 10.1016/j.neuroscience.2014.07.024
    1. Forte R, Tocci N, De Vito G. The Impact of Exercise Intervention with Rhythmic Auditory Stimulation to Improve Gait and Mobility in Parkinson Disease: An Umbrella Review. Brain Sci. 2021;11(6).
    1. Gonçalves HR, Rodrigues AM, Santos CP. Vibrotactile biofeedback devices in Parkinson’s disease: a narrative review. Medical & biological engineering & computing. 2021;59(6):1185–99. doi: 10.1007/s11517-021-02365-3
    1. Keus SHJ, Bloem BR, Hendriks EJM, Bredero-Cohen AB, Munneke M. Evidence-based analysis of physical therapy in Parkinson’s disease with recommendations for practice and research. Movement Disorders. 2007;22(4):451–60. doi: 10.1002/mds.21244
    1. Rochester L, Lord S, Morris ME. The role of physiotherapy in the rehabilitation of people with movement disorders. In: Morris ME, Iansek R, editors. Rehabilitation in Movement Disorders. Cambridge: Cambridge University Press; 2013. p. 55–68.
    1. Gräber S, Liepelt-Scarfone I, Csoti I, Maetzler W, Sultan F, Berg D. Post-cueing deficits with maintained cueing benefits in patients with Parkinson’s disease dementia. Front Neurol. 2014;5:236. doi: 10.3389/fneur.2014.00236
    1. Rochester L, Baker K, Hetherington V, Jones D, Willems A-M, Kwakkel G, et al.. Evidence for motor learning in Parkinson’s disease: Acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues. Brain Research. 2010;1319:103–11. doi: 10.1016/j.brainres.2010.01.001
    1. Harrison EC, Horin AP, Earhart GM. Internal cueing improves gait more than external cueing in healthy adults and people with Parkinson disease. Scientific Reports. 2018;8(1):15525. doi: 10.1038/s41598-018-33942-6
    1. Lirani-Silva E, Lord S, Moat D, Rochester L, Morris R. Auditory Cueing for Gait Impairment in Persons With Parkinson Disease: A Pilot Study of Changes in Response With Disease Progression. Journal of Neurologic Physical Therapy. 2019;43(1):50–5. doi: 10.1097/NPT.0000000000000250
    1. Suteerawattananon M, Morris GS, Etnyre BR, Jankovic J, Protas EJ. Effects of visual and auditory cues on gait in individuals with Parkinson’s disease. Journal of the neurological sciences. 2004;219(1–2):63–9. doi: 10.1016/j.jns.2003.12.007
    1. Morris ME, Martin CL, Schenkman ML. Striding out with Parkinson disease: evidence-based physical therapy for gait disorders. Physical therapy. 2010;90(2):280–8. doi: 10.2522/ptj.20090091
    1. Cunnington R, Iansek R, Bradshaw JL. Movement-related potentials in Parkinson’s disease: external cues and attentional strategies. Movement disorders: official journal of the Movement Disorder Society. 1999;14(1):63–8. doi: 10.1002/1531-8257(199901)14:1<63::aid-mds1012>;2-v
    1. Johansson R, Westling G. Roles of glabrous skin receptors and sensorimotor memory in automatic control of precision grip when lifting rougher or more slippery objects. Experimental brain research. 1984;56(3):550–64. doi: 10.1007/BF00237997
    1. Rabin E, Gordon AM. Prior experience and current goals affect muscle-spindle and tactile integration. Experimental brain research. 2006;169(3):407–16. doi: 10.1007/s00221-005-0154-3
    1. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson’s disease. Normalization strategies and underlying mechanisms. Brain. 1996;119 (Pt 2):551–68. doi: 10.1093/brain/119.2.551
    1. Stuart S, Vitorio R, Morris R, Martini DN, Fino PC, Mancini M. Cortical activity during walking and balance tasks in older adults and in people with Parkinson’s disease: A structured review. Maturitas. 2018;113:53–72. doi: 10.1016/j.maturitas.2018.04.011
    1. Stuart S, Mancini M. Prefrontal Cortical Activation With Open and Closed-Loop Tactile Cueing When Walking and Turning in Parkinson Disease: A Pilot Study. Journal of Neurologic Physical Therapy. 2019;Publish Ahead of Print.
    1. Morris R, Lord S, Bunce J, Burn D, Rochester L. Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease. Neuroscience and biobehavioral reviews. 2016;64:326–45. doi: 10.1016/j.neubiorev.2016.02.012
    1. Aikman GGaO M.E. Geriatric Depression Scale: Long Form Versus Short Form. Clinical Gerontologist. 2000;22(3/4):63–70.
    1. Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, et al.. The MoCA: Well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75:1717–25. doi: 10.1212/WNL.0b013e3181fc29c9
    1. Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T, et al.. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson’s disease and their carers. Gait Posture. 2009;30(4):459–63. doi: 10.1016/j.gaitpost.2009.07.108
    1. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al.. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement disorders: official journal of the Movement Disorder Society. 2008;23(15):2129–70. doi: 10.1002/mds.22340
    1. Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, et al.. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75(19):1717–25. doi: 10.1212/WNL.0b013e3181fc29c9
    1. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. Journal of neurology, neurosurgery, and psychiatry. 1998;64(5):588–94. doi: 10.1136/jnnp.64.5.588
    1. Calamia M, Markon K, Denburg NL, Tranel D. Developing a short form of Benton’s Judgment of Line Orientation Test: an item response theory approach. The Clinical neuropsychologist. 2011;25(4):670–84. doi: 10.1080/13854046.2011.564209
    1. Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age and ageing. 2005;34(6):614–9. doi: 10.1093/ageing/afi196
    1. Stuart S, Belluscio V, Quinn JF, Mancini M. Pre-frontal Cortical Activity During Walking and Turning Is Reliable and Differentiates Across Young, Older Adults and People With Parkinson’s Disease. Frontiers in Neurology. 2019;10(536). doi: 10.3389/fneur.2019.00536
    1. Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. Journal of neuroscience methods. 2004;134(1):9–21. doi: 10.1016/j.jneumeth.2003.10.009
    1. Makeig S, Bell AJ, Jung T-P, Sejnowski TJ, editors. Independent component analysis of electroencephalographic data. Advances in neural information processing systems; 1996.
    1. Pion-Tonachini L, Kreutz-Delgado K, Makeig S. ICLabel: An automated electroencephalographic independent component classifier, dataset, and website. NeuroImage. 2019;198:181–97. doi: 10.1016/j.neuroimage.2019.05.026
    1. Beretta VS, Conceição NR, Nóbrega-Sousa P, Orcioli-Silva D, Dantas L, Gobbi LTB, et al.. Transcranial direct current stimulation combined with physical or cognitive training in people with Parkinson’s disease: a systematic review. Journal of neuroengineering and rehabilitation. 2020;17(1):74. doi: 10.1186/s12984-020-00701-6
    1. Conceição NR, Gobbi LTB, Nóbrega-Sousa P, Orcioli-Silva D, Beretta VS, Lirani-Silva E, et al.. Aerobic Exercise Combined With Transcranial Direct Current Stimulation Over the Prefrontal Cortex in Parkinson Disease: Effects on Cortical Activity, Gait, and Cognition. Neurorehabilitation and neural repair. 2021;35(8):717–28. doi: 10.1177/15459683211019344

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever